Tuesday, March 2, 2021
Home Life Style Health & Fitness Scientists hopeful of 'full-length single chain' AIDS vaccine

Scientists hopeful of ‘full-length single chain’ AIDS vaccine

NewsGram Staff Writer

Robert Gallo, the scientist who first proved in 1984 that HIV triggered the disease AIDS, is again all set to begin the trial of its vaccine in the US. The vaccine which has been developed over the past 15 years by Gallo is a little different and is expected to bear fruitful results.

The initial phase, involving 60 volunteers, will test the safety and immune responses of the vaccine. This study will reveal whether the vaccine is more effective than the other 100+ AIDS vaccines that have been tested over the last three decades. Extensive testing on monkeys have yielded positive results.

Despite the presence of potential vaccines, the challenge with AIDS is that HIV directly infects white blood cells (RBC) called T-cells, so it literally turns our immune system against us. So, once the virus enters a T-cell, it’s invisible to the immune system.

The sole possibility to combat the threat is to pump in antibodies against the HIV surface proteins. However, doing so is equally difficult owing to the fact that the retrovirus can regularly change its viral envelope to hide particular surface proteins.

But Gallo and his team at the Institute of Human Virology in USA believe that they may have now found a moment when the HIV surface protein, known as gp120, is vulnerable to detection – the moment the virus binds with our bodies’ T-cells.

When HIV infects a patient, it first links to the CD4 receptor on the white blood cell. It then transitions, exposing hidden parts of its viral envelope, which allow it to bind to a second receptor called CCR5. Once HIV is attached to both these T-cell receptors, it can successfully infect the immune cell. at this stage, it is impossible to stop its juggernaut.

Gallo’s “full-length single chain” vaccine contains the HIV surface protein gp120, engineered to link to a few portions of the CD4 receptor. The motive is to fuel antibodies against gp120 when it is already attached to CD4 and is in a vulnerable transitional state. The aim of the whole process is effectively stopping it from attaching to the second CCR5 attachment.

Gallo himself admitted to Jon Cohen over at Science that full-length single chain vaccine is a “terrible name”.

The trial is being run in collaboration with Profectus BioSciences, a biotech spin-off from the Institute of Human Virology, and Gallo explained that extreme thorough testing on monkey and getting the fund to develop a human-grade vaccine have resulted in a delay to get to this point.

“Was anything a lack of courage?” he asked Science. “Sure. We wanted more and more answers before going into people.”

Let’s hope that caution pays off, and we may finally have a viable contender for an AIDS vaccine on our hands.

(With inputs from www.sciencealert.com)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

Mission Shakti Program: Girl Students In UP To Learn Self Defense

Under the ongoing Mission Shakti program, girl students in more than 40,000 upper primary schools will learn self-defense techniques between March 1 and 31. According...

AR Apps Powered By Apple App Store For Your Younger Ones

If you wish to aid the development of a scientific temper in your kids with the help of augmented reality (AR) on the occasion...

New AI Feature To Animate The Faces In Still Photos

 What if you could make your late grandfather in an old photo look up and smile at you? This and numerous other possibilities have...

Just One Vaccine Shot Reduces The Risk Of Being Hospitalized By Covid-19

Just one vaccine shot reduces the risk of being hospitalized by Covid-19 by more than 90 percent, according to new findings, Daily Mail reported....

Government of India Prepares a Master Plan To Promote Toy Industry

Guruprasad Mohapatra, Secretary for the Department for Promotion of Industry and Internal Trade, said that toys are of serious economic concern and a very...

Obstructive Sleep Apnea Linked To Lower Score Of Memory Skills

A disorder called obstructive sleep apnea that occurs when breathing is repeatedly interrupted during sleep is common in people with thinking and memory problems,...

How A Single Thought Or Argument Takes The Shape Of A Disease?

When we break the word 'disease', it comes through as 'dis' and 'ease' -- something that is not at ease. Anything which makes you...

Check Out New Courses For Journalism Field Offered By Google India

Data journalism, reverse visual search and mobile journalism are among the new courses that the Google News Initiative announced on Monday. The new courses are...

Recent Comments